Skip to main content
PMC home page
American Journal of Human Genetics logoLink to American Journal of Human Genetics
. 1992 Oct;51(4):810–820.

Gaucher disease: A G+1----A+1 IVS2 splice donor site mutation causing exon 2 skipping in the acid beta-glucosidase mRNA.

G S He 1, G A Grabowski 1
PMCID: PMC1682814  PMID: 1415223

Abstract

Gaucher disease is the most frequent lysosomal storage disease and the most prevalent Jewish genetic disease. About 30 identified missense mutations are causal to the defective activity of acid beta-glucosidase in this disease. cDNAs were characterized from a moderately affected 9-year-old Ashkenazi Jewish Gaucher disease type 1 patient whose 80-year-old, enzyme-deficient, 1226G (Asn370----Ser [N370S]) homozygous grandfather was nearly asymptomatic. Sequence analyses revealed four populations of cDNAs with either the 1226G mutation, an exact exon 2 (delta EX2) deletion, a deletion of exon 2 and the first 115 bp of exon 3 (delta EX2-3), or a completely normal sequence. About 50% of the cDNAs were the delta EX2, the delta EX2-3, and the normal cDNAs, in a ratio of 6:3:1. Specific amplification and characterization of exon 2 and 5' and 3' intronic flanking sequences from the structural gene demonstrated clones with either the normal sequence or with a G+1----A+1 transition at the exon 2/intron 2 boundary. This mutation destroyed the splice donor consensus site (U1 binding site) for mRNA processing. This transition also was present at the corresponding exon/intron boundary of the highly homologous pseudogene. This new mutation, termed "IVS2 G+1----A+1," is the first splicing mutation described in Gaucher disease and accounted for about 3.4% of the Gaucher disease alleles in the Ashkenazi Jewish population. The occurrence of this "pseudogene"-type mutation in the structural gene indicates the role of acid beta-glucosidase pseudogene and structural gene rearrangements in the pathogenesis of this disease.

Full text

PDF
813

Images in this article

816Figure 5
on p.816
815Figure 4
on p.815
817Figure 6
on p.817
817Figure 7
on p.817
818Figure 8
on p.818

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barneveld R. A., Keijzer W., Tegelaers F. P., Ginns E. I., Geurts van Kessel A., Brady R. O., Barranger J. A., Tager J. M., Galjaard H., Westerveld A. Assignment of the gene coding for human beta-glucocerebrosidase to the region q21-q31 of chromosome 1 using monoclonal antibodies. Hum Genet. 1983;64(3):227–231. doi: 10.1007/BF00279398. [DOI] [PubMed] [Google Scholar]
  2. Barton N. W., Brady R. O., Dambrosia J. M., Di Bisceglie A. M., Doppelt S. H., Hill S. C., Mankin H. J., Murray G. J., Parker R. I., Argoff C. E. Replacement therapy for inherited enzyme deficiency--macrophage-targeted glucocerebrosidase for Gaucher's disease. N Engl J Med. 1991 May 23;324(21):1464–1470. doi: 10.1056/NEJM199105233242104. [DOI] [PubMed] [Google Scholar]
  3. Barton N. W., Furbish F. S., Murray G. J., Garfield M., Brady R. O. Therapeutic response to intravenous infusions of glucocerebrosidase in a patient with Gaucher disease. Proc Natl Acad Sci U S A. 1990 Mar;87(5):1913–1916. doi: 10.1073/pnas.87.5.1913. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Beutler E. Gaucher's disease. N Engl J Med. 1991 Nov 7;325(19):1354–1360. doi: 10.1056/NEJM199111073251906. [DOI] [PubMed] [Google Scholar]
  5. Beutler E., Gelbart T., Kuhl W., Sorge J., West C. Identification of the second common Jewish Gaucher disease mutation makes possible population-based screening for the heterozygous state. Proc Natl Acad Sci U S A. 1991 Dec 1;88(23):10544–10547. doi: 10.1073/pnas.88.23.10544. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Beutler E., Kay A., Saven A., Garver P., Thurston D., Dawson A., Rosenbloom B. Enzyme replacement therapy for Gaucher disease. Blood. 1991 Sep 1;78(5):1183–1189. [PubMed] [Google Scholar]
  7. Chen E. Y., Seeburg P. H. Supercoil sequencing: a fast and simple method for sequencing plasmid DNA. DNA. 1985 Apr;4(2):165–170. doi: 10.1089/dna.1985.4.165. [DOI] [PubMed] [Google Scholar]
  8. Conzelmann E., Sandhoff K. Partial enzyme deficiencies: residual activities and the development of neurological disorders. Dev Neurosci. 1983;6(1):58–71. doi: 10.1159/000112332. [DOI] [PubMed] [Google Scholar]
  9. Devine E. A., Smith M., Arredondo-Vega F. X., Shafit-Zagardo B., Desnick R. J. Chromosomal localization of the gene for Gaucher disease. Prog Clin Biol Res. 1982;95:511–534. [PubMed] [Google Scholar]
  10. Dreborg S., Erikson A., Hagberg B. Gaucher disease--Norrbottnian type. I. General clinical description. Eur J Pediatr. 1980 Mar;133(2):107–118. doi: 10.1007/BF00441578. [DOI] [PubMed] [Google Scholar]
  11. Fallet S., Grace M. E., Sibille A., Mendelson D. S., Shapiro R. S., Hermann G., Grabowski G. A. Enzyme augmentation in moderate to life-threatening Gaucher disease. Pediatr Res. 1992 May;31(5):496–502. doi: 10.1203/00006450-199205000-00018. [DOI] [PubMed] [Google Scholar]
  12. Grabowski G. A., Dinur T., Gatt S., Desnick R. J. Gaucher type I (Ashkenazi) disease: a new method for heterozygote detection using a novel fluorescent natural substrate. Clin Chim Acta. 1982 Sep 1;124(1):123–135. doi: 10.1016/0009-8981(82)90326-6. [DOI] [PubMed] [Google Scholar]
  13. Grabowski G. A., Gatt S., Horowitz M. Acid beta-glucosidase: enzymology and molecular biology of Gaucher disease. Crit Rev Biochem Mol Biol. 1990;25(6):385–414. doi: 10.3109/10409239009090616. [DOI] [PubMed] [Google Scholar]
  14. Grabowski G. A., Goldblatt J., Dinur T., Kruse J., Svennerholm L., Gatt S., Desnick R. J. Genetic heterogeneity in Gaucher disease: physicokinetic and immunologic studies of the residual enzyme in cultured fibroblasts from non-neuronopathic and neuronopathic patients. Am J Med Genet. 1985 Jul;21(3):529–549. doi: 10.1002/ajmg.1320210316. [DOI] [PubMed] [Google Scholar]
  15. Grace M. E., Berg A., He G. S., Goldberg L., Horowitz M., Grabowski G. A. Gaucher disease: heterologous expression of two alleles associated with neuronopathic phenotypes. Am J Hum Genet. 1991 Sep;49(3):646–655. [PMC free article] [PubMed] [Google Scholar]
  16. Grace M. E., Graves P. N., Smith F. I., Grabowski G. A. Analyses of catalytic activity and inhibitor binding of human acid beta-glucosidase by site-directed mutagenesis. Identification of residues critical to catalysis and evidence for causality of two Ashkenazi Jewish Gaucher disease type 1 mutations. J Biol Chem. 1990 Apr 25;265(12):6827–6835. [PubMed] [Google Scholar]
  17. Hong C. M., Ohashi T., Yu X. J., Weiler S., Barranger J. A. Sequence of two alleles responsible for Gaucher disease. DNA Cell Biol. 1990 May;9(4):233–241. doi: 10.1089/dna.1990.9.233. [DOI] [PubMed] [Google Scholar]
  18. Horowitz M., Wilder S., Horowitz Z., Reiner O., Gelbart T., Beutler E. The human glucocerebrosidase gene and pseudogene: structure and evolution. Genomics. 1989 Jan;4(1):87–96. doi: 10.1016/0888-7543(89)90319-4. [DOI] [PubMed] [Google Scholar]
  19. Latham T. E., Theophilus B. D., Grabowski G. A., Smith F. I. Heterogeneity of mutations in the acid beta-glucosidase gene of Gaucher disease patients. DNA Cell Biol. 1991 Jan-Feb;10(1):15–21. doi: 10.1089/dna.1991.10.15. [DOI] [PubMed] [Google Scholar]
  20. Latham T., Grabowski G. A., Theophilus B. D., Smith F. I. Complex alleles of the acid beta-glucosidase gene in Gaucher disease. Am J Hum Genet. 1990 Jul;47(1):79–86. [PMC free article] [PubMed] [Google Scholar]
  21. Ohashi T., Hong C. M., Weiler S., Tomich J. M., Aerts J. M., Tager J. M., Barranger J. A. Characterization of human glucocerebrosidase from different mutant alleles. J Biol Chem. 1991 Feb 25;266(6):3661–3667. [PubMed] [Google Scholar]
  22. Reiner O., Wilder S., Givol D., Horowitz M. Efficient in vitro and in vivo expression of human glucocerebrosidase cDNA. DNA. 1987 Apr;6(2):101–108. doi: 10.1089/dna.1987.6.101. [DOI] [PubMed] [Google Scholar]
  23. Sorge J., West C., Westwood B., Beutler E. Molecular cloning and nucleotide sequence of human glucocerebrosidase cDNA. Proc Natl Acad Sci U S A. 1985 Nov;82(21):7289–7293. doi: 10.1073/pnas.82.21.7289. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Theophilus B. D., Latham T., Grabowski G. A., Smith F. I. Comparison of RNase A, a chemical cleavage and GC-clamped denaturing gradient gel electrophoresis for the detection of mutations in exon 9 of the human acid beta-glucosidase gene. Nucleic Acids Res. 1989 Oct 11;17(19):7707–7722. doi: 10.1093/nar/17.19.7707. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Theophilus B., Latham T., Grabowski G. A., Smith F. I. Gaucher disease: molecular heterogeneity and phenotype-genotype correlations. Am J Hum Genet. 1989 Aug;45(2):212–225. [PMC free article] [PubMed] [Google Scholar]
  26. Tsuji S., Choudary P. V., Martin B. M., Stubblefield B. K., Mayor J. A., Barranger J. A., Ginns E. I. A mutation in the human glucocerebrosidase gene in neuronopathic Gaucher's disease. N Engl J Med. 1987 Mar 5;316(10):570–575. doi: 10.1056/NEJM198703053161002. [DOI] [PubMed] [Google Scholar]
  27. Tsuji S., Martin B. M., Barranger J. A., Stubblefield B. K., LaMarca M. E., Ginns E. I. Genetic heterogeneity in type 1 Gaucher disease: multiple genotypes in Ashkenazic and non-Ashkenazic individuals. Proc Natl Acad Sci U S A. 1988 Apr;85(7):2349–2352. doi: 10.1073/pnas.85.7.2349. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Zimran A., Gelbart T., Westwood B., Grabowski G. A., Beutler E. High frequency of the Gaucher disease mutation at nucleotide 1226 among Ashkenazi Jews. Am J Hum Genet. 1991 Oct;49(4):855–859. [PMC free article] [PubMed] [Google Scholar]
  29. Zimran A., Sorge J., Gross E., Kubitz M., West C., Beutler E. A glucocerebrosidase fusion gene in Gaucher disease. Implications for the molecular anatomy, pathogenesis, and diagnosis of this disorder. J Clin Invest. 1990 Jan;85(1):219–222. doi: 10.1172/JCI114415. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from American Journal of Human Genetics are provided here courtesy of American Society of Human Genetics

RESOURCES